BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
40.92
+0.65 (1.61%)
Mar 6, 2026, 4:00 PM EST
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 17.02 billion as of March 9, 2026. Its market cap has increased by 32.34% in one year.
Market Cap
17.02B
Enterprise Value
18.83B
Revenue
1.22B
Ranking
n/a
PE Ratio
303.54
Stock Price
40.92
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 17.02B, an increase of 35.58%. That is a compound annual growth rate of 4.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.76B |
| Jinyu Bio-technology | 16.34B |
| Anhui Anke Biotechnology (Group) | 16.07B |
| Inner Mongolia Furui Medical Science | 15.10B |
| Tibet Cheezheng Tibetan Medicine | 14.22B |
| Vcanbio Cell & Gene Engineering Corp., | 14.09B |
| Suzhou Zelgen Biopharmaceuticals | 21.75B |
| Mabwell (Shanghai) Bioscience | 13.66B |